Andreas L Norlin

Andreas L Norlin Email and Phone Number

Drug Discovery and Development | Strategy and Execution @ Desupervised
denmark
Andreas L Norlin's Location
Greater Malmö Metropolitan Area, Sweden
Andreas L Norlin's Contact Details

Andreas L Norlin personal email

n/a
About Andreas L Norlin

More than 20 years in research, pre-clinical and clinical development from academia, biotech and big pharma has given a me deep knowledge of drug development strategy and execution. I have a broad R&D management experience profile including project management, people leadership, line management and external collaborations (academia, in- and out-licensing activities) within diabetes, inflammatory disease and drug delivery technologies.My leadership style is people oriented, which means I set patients’ need in focus of drug development and build teams where everyone is visible. Making fact-based decisions and keep focus on the most important thing at each time are highly important principles for me.My hands-on experience includes (key words): Target Product Profile | Project valuation | Regulatory affairs (IND, IMPD, CTD, scientific advice) | Effective Company Directorship (Certificated) | Budget | People Development | Strength-based leadership | Coaching | Risk assessment | Portfolio management | Safety assessment | Stakeholder management | Negotiation | Due diligence | Tech transfer | Corporate alliances | Toxicology | Pharmacokinetics (DMPK) |Pharmacology | Statistical analysis | Outsourcing of pre-clinical and clinical studies | Organisation | Cross-functional projects | Networking | ICH | GLP and GCP | Business case evaluation | Discovery | Patient organisations | CMC | Quality | Product supply | Device development | Excipient qualification

Andreas L Norlin's Current Company Details
Desupervised

Desupervised

View
Drug Discovery and Development | Strategy and Execution
denmark
Website:
desupervised.io
Employees:
9
Andreas L Norlin Work Experience Details
  • Desupervised
    Non Executive Chair
    Desupervised Nov 2023 - Present
    Copenhagen Metropolitan Area
    View
  • Ascelia Pharma Ab
    Chief Scientific Officer
    Ascelia Pharma Ab Oct 2022 - Present
    Malmö, Skåne County, Sweden
    Ascelia Pharma is an oncology-dedicated drug development company located in Malmö, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. Our strategy is to identify, develop and commercialize novel drugs that address unmet needs of people with rare cancer conditions. Ascelia Pharma is fully focused on two clinical-stage product candidates under development: Orviglance and Oncoral.
    View
  • Ascelia Pharma Ab
    Vice President Research And Development
    Ascelia Pharma Ab Jan 2022 - Oct 2022
    Malmö, Skåne County, Sweden
    View
  • Ascelia Pharma Ab
    Project Director And Head Of Preclinical Development
    Ascelia Pharma Ab Apr 2020 - Jan 2022
    Malmö, Skane County, Sweden
    View
  • Apoglyx
    Non Executive Board Member
    Apoglyx Dec 2017 - Present
    Lund, Sweden
    Apoglyx is a start-up company exploring opportunities for its propreitary Aquaporin-9 inhibitors in type 2 diabetes and other diseases.
  • Xkout Bioscience
    Senior Advisor
    Xkout Bioscience Feb 2017 - Present
    Scandinavia
    Support to academic research groups, investors, start-ups and more mature biotech and pharma companies in bringing new candidate drugs from the discovery phase into and through clinical development. I work as independent consultant or as a long-term partner, depending on the company's needs and strategic goals.www.xkout-bioscience.com
    View
  • Varct Diagnostics
    Chief Operating Officer
    Varct Diagnostics Jun 2017 - Mar 2020
    Copenhagen Area, Denmark
    Developing cancer diagnostics based on the VAR2 malaria protein, with the aim to bring a robust method for early detection of cancer to the market.
    View
  • Var2 Pharmaceuticals
    Chief Operating Officer
    Var2 Pharmaceuticals May 2017 - Mar 2020
    Copenhagen Area, Denmark
    Driving the development activities for new cancer therapies based on the VAR2 protein technology, a proprietary therapeutic protein targeting cancer-specific carbohydrate structures for multiple cancer indications.
    View
  • Novo Nordisk
    Project Vice President
    Novo Nordisk Jan 2014 - Nov 2016
    Copenhagen Area, Denmark
    Leading global projects within the inflammatory disease and diabetes areas.> Headed up multiple projects and project teams> Initiated Novo Nordisk's first clinical phase 2 trial testing a new combination treatment aiming to prevent beta-cell function in newly diagnosed Type 1 diabetes (see https://clinicaltrials.gov/ct2/show/NCT02443155?term=NN9828-4150&rank=1)> Regulatory interactions: Type C and Type B meetings with FDA, sceintific advice with Swedish and German health authorities.> Responsible for development of business cases and evaluation of two new indication areas> Member of area management team(s), including department head for approximately 9 months, with strong focus on people development within projects teams and across departments> Responsible for the management of closing Inflammation projects (following Novo Nordisk's decision to discontinue all R&D in Inflammation in September 2014)> Heading the project teams supporting the successful out-licensing of Inflammation assets
    View
  • Novo Nordisk
    Senior Non-Clinical Project Manager
    Novo Nordisk Apr 2008 - Dec 2013
    Copenhagen Area, Denmark
    Non-clinical project management within the diabetes area> Heading up the project team that made the preclinical qualification of subcutaneous semaglutide (recently filed to the FDA and EMA: see http://www.novonordisk.com/media/news-details.2061793.html) and oral semaglutide (currently in phase 3 development: see http://www.novonordisk.com/media/news-details.1947638.html)> Multiple regulatory interactions: End of Phase 2 meetings with FDA, PMDA (Japan) and European health authorities. Scientific advice meetings with UK (MHRA) and German (BfArM) health authorities.> Working with preclinical qualification of both drugs and novel excipients (absorption enhancers)> Driving cross-project aligment initiatves> Promoting feedback culture and people focus in project teams> Due diligence (support to in-licensing)
    View
  • Sötrönnen Ab
    Member Of The Board
    Sötrönnen Ab Nov 2010 - Oct 2014
    Malmo, Sweden
    Sötrönnen AB is a privately owned property management business, with its main assets in pre-school and school property.I was member of the board, deputy chairman (1 year) and secretary of the board (2 years).
  • Malmö Montessoriskola Ab
    Member Of The Board
    Malmö Montessoriskola Ab Nov 2010 - Oct 2014
    Malmo, Sweden
    Malmö Montessoriskola AB is a privately owned, non-profit, pre- and elementary school. The school has around 100 pre-school children and 300 elementary school pupils and a staff of around 80 people.I was member of the board, deputy chairman (1 year) and secretary of the board (2 years).http://montessoriskolan.com/
  • Camurus
    Director Preclinical R&D
    Camurus Jan 2003 - Mar 2008
    Lund, Sweden
    Managing in vivo laboratory staff and pre-clinical development projects.> Setting up laboratory and animal test models for testing and evaluation of novel drug delivery technology by oral, subcutaneous (short- and long-acting depots), topical (skin), buccal, nasal and intravenous routes> Instrumental in driving three projects to clinical development in different indication areas (see for example CAM2032 on http://camurus.se/products/)> Managing clinical phase 1 trials> Medical writing (multiple Investigator's Brochures, summary documents)> Supporting out-licensing of projects and contract negotitations> Regulatory scientific advice with the Austrian health authority> Outsourcing of around 40 studies, including GLP toxicology studies to qualify novel excipient
    View
  • Camurus
    Preclinical Research Manager
    Camurus Apr 2001 - Dec 2002
    Lund, Sweden
    Planning, execution/outsourcing and reporting of non-clinical in vitro and in vivo studies, as well as clinical trial planning.
    View
  • Lunds Universitet
    Postgraduate Student / Phd Student
    Lunds Universitet Jun 1996 - Dec 2000
    Lund, Sweden
    Research (part time, 85%):> Department of Animal Physiology: PhD project with focus on epithelial transport mechanisms with focus on development and regulation of ion transport proteins in the alveolar epithelium> Developing in vivo model for quantifying pulmonary fluid absorption in pre- and postnatal guinea pigs> Postgraduate member of the department board> Chairing the post-graduate student organisation at the department, representative in the Post-graduate student association at Lund University 1998 to 2000Teaching and lecturing (part time, 15%):> Organising post-graduate course in scieftifc and method and bioethics> In vivo techniques (aneasthesia, blood vessel catheterization, tracheostomey/ventilation)> In vitro organ experimental techniques> Developing human (electro-physiology) exercises> Supervising > 10 graduate projects
    View

Andreas L Norlin Skills

Clinical Development R&d Non Clinical Project Management Line Management In Vivo Physiology Pharmacokinetics Regulatory Affairs Lecturing Pharmaceutical Industry Clinical Trials Drug Discovery Diabetes Regulatory Requirements Drug Development Clinical Research Pharmacology Fda Leadership Management Biotechnology Life Sciences Strategic Planning Cross Functional Team Leadership Presentations In/out Licensing Strategy Scientific Writing

Andreas L Norlin Education Details

Frequently Asked Questions about Andreas L Norlin

What company does Andreas L Norlin work for?

Andreas L Norlin works for Desupervised

What is Andreas L Norlin's role at the current company?

Andreas L Norlin's current role is Drug Discovery and Development | Strategy and Execution.

What is Andreas L Norlin's email address?

Andreas L Norlin's email address is ua****@****isk.com

What schools did Andreas L Norlin attend?

Andreas L Norlin attended Copenhagen Business School, Harvard Business School, Copenhagen Business School, Lund University, Lund University, Lund University.

What are some of Andreas L Norlin's interests?

Andreas L Norlin has interest in Health, Animal Welfare, Environment, Science And Technology.

What skills is Andreas L Norlin known for?

Andreas L Norlin has skills like Clinical Development, R&d, Non Clinical, Project Management, Line Management, In Vivo, Physiology, Pharmacokinetics, Regulatory Affairs, Lecturing, Pharmaceutical Industry, Clinical Trials.

Who are Andreas L Norlin's colleagues?

Andreas L Norlin's colleagues are Amir Bhatti, Thareq Yusuf, Martyna Trojgo, Mykyta Voitishyn, Nizom Sidiq.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.